{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:52:19Z","timestamp":1783029139356,"version":"3.54.6"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,2,18]],"date-time":"2009-02-18T00:00:00Z","timestamp":1234915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1245\/s10434-009-0350-7","type":"journal-article","created":{"date-parts":[[2009,2,17]],"date-time":"2009-02-17T10:04:27Z","timestamp":1234865067000},"page":"1176-1183","source":"Crossref","is-referenced-by-count":37,"title":["Microscopic Satellitosis in Patients with Primary Cutaneous Melanoma: Implications for Nodal Basin Staging"],"prefix":"10.1245","volume":"16","author":[{"given":"Troy F.","family":"Kimsey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. J.","family":"Busam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,18]]},"reference":[{"key":"350_CR1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"AA Jemal","year":"2008","unstructured":"Jemal AA, Siegel RR, Ward EE, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71\u201396.","journal-title":"CA Cancer J Clin"},{"key":"350_CR2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s10434-001-0328-6","volume":"8","author":"BM Clary","year":"2001","unstructured":"Clary BM, Mann B, Brady MS, Lewis JJ, Coit DG. Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissection. Ann Surg Oncol. 2001;8:328\u201337.","journal-title":"Ann Surg Oncol"},{"key":"350_CR3","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1001\/archsurg.1992.01420120046008","volume":"127","author":"MA Gadd","year":"1992","unstructured":"Gadd MA, Coit DG. Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma. Arch Surg. 1992;127:1412\u20136.","journal-title":"Arch Surg"},{"key":"350_CR4","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1200\/JCO.1998.16.6.2253","volume":"16","author":"JE Gershenwald","year":"1998","unstructured":"Gershenwald JE, Colome MI, Lee JE, Mansfield PF, Tseng C, Lee JJ, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol. 1998;16:2253\u201360.","journal-title":"J Clin Oncol"},{"key":"350_CR5","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0889-8588(05)70022-8","volume":"12","author":"WK Stadelmann","year":"1998","unstructured":"Stadelmann WK, Reintgen DS. Prognosis in malignant melanoma. Hematol Oncol Clin North Am. 1998;12:767\u201396, vi","journal-title":"Hematol Oncol Clin North Am"},{"key":"350_CR6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ssu.10020","volume":"21","author":"CM Balch","year":"2003","unstructured":"Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Semin Surg Oncol. 2003;21:43\u201352.","journal-title":"Semin Surg Oncol."},{"key":"350_CR7","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622\u201334.","journal-title":"J Clin Oncol"},{"key":"350_CR8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00000658-199110000-00013","volume":"214","author":"DL Morton","year":"1991","unstructured":"Morton DL, Wanek L, Nizze JA, Elashoff RM, Wong JH. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg. 1991;214:491\u20139; discussion 499\u2013501.","journal-title":"Ann Surg"},{"key":"350_CR9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00000658-198107000-00019","volume":"194","author":"CL Day Jr","year":"1981","unstructured":"Day CL Jr, Harrist TJ, Gorstein F, Sober AJ, Lew RA, Friedman RJ, et al. Malignant melanoma. Prognostic significance of \u201cmicroscopic satellites\u201d in the reticular dermis and subcutaneous fat. Ann Surg. 1981;194:108\u201312.","journal-title":"Ann Surg"},{"key":"350_CR10","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/1097-0142(19840515)53:10<2183::AID-CNCR2820531029>3.0.CO;2-9","volume":"53","author":"TJ Harrist","year":"1984","unstructured":"Harrist TJ, Rigel DS, Day CL Jr, Sober AJ, Lew RA, Rhodes AR, et al. \u201cMicroscopic satellites\u201d are more highly associated with regional lymph node metastases than is primary melanoma thickness. Cancer. 1984;53:2183\u20137.","journal-title":"Cancer"},{"key":"350_CR11","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/archsurg.1991.01410360031006","volume":"126","author":"P Leon","year":"1991","unstructured":"Leon P, Daly JM, Synnestvedt M, Schultz DJ, Elder DE, Clark WH Jr. The prognostic implications of microscopic satellites in patients with clinical stage I melanoma. Arch Surg. 1991;126:1461\u20138.","journal-title":"Arch Surg"},{"key":"350_CR12","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1200\/JCO.1997.15.3.1039","volume":"15","author":"AC Buzaid","year":"1997","unstructured":"Buzaid AC, Ross MI, Balch CM, Soong S, McCarthy WH, Tinoco L, et al. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol. 1997;15:1039\u201351.","journal-title":"J Clin Oncol"},{"key":"350_CR13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3322\/canjclin.54.3.131","volume":"54","author":"CM Balch","year":"2004","unstructured":"Balch CM, Soong SJ, Atkins MB, Buzaid AC, Cascinelli N, Coit DG, et al. An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin. 2004;54:131\u201349; quiz 182\u201334.","journal-title":"CA Cancer J Clin"},{"key":"350_CR14","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1001\/archderm.1985.01660090041010","volume":"121","author":"PH Cooper","year":"1985","unstructured":"Cooper PH, Wanebo HJ, Hagar RW. Regression in thin malignant melanoma. Microscopic diagnosis and prognostic importance. Arch Dermatol. 1985;121:1127\u201331.","journal-title":"Arch Dermatol"},{"key":"350_CR15","first-page":"1071","volume":"69","author":"FE Harrell Jr","year":"1985","unstructured":"Harrell FE Jr, Lee KL, Matchar DB, Reichert TA. Regression models for prognostic prediction: advantages, problems, and suggested solutions. Cancer Treat Rep. 1985;69:1071\u20137.","journal-title":"Cancer Treat Rep"},{"key":"350_CR16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361\u201387.","journal-title":"Stat Med"},{"key":"350_CR17","first-page":"175","volume":"12","author":"N Cascinelli","year":"1986","unstructured":"Cascinelli N, Bufalino R, Marolda R, Belli F, Nava M, Galluzzo D, et al. Regional non-nodal metastases of cutaneous melanoma. Eur J Surg Oncol. 1986;12:175\u201380.","journal-title":"Eur J Surg Oncol"},{"key":"350_CR18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00000658-199111000-00014","volume":"214","author":"DG Coit","year":"1991","unstructured":"Coit DG, Rogatko A, Brennan MF. Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis. Ann Surg. 1991;214:627\u201336.","journal-title":"Ann Surg"},{"key":"350_CR19","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1200\/JCO.1995.13.11.2776","volume":"13","author":"ET Creagan","year":"1995","unstructured":"Creagan ET, Dalton RJ, Ahmann DL, Jung SH, Morton RF, Langdon RM Jr, et al. Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma. J Clin Oncol. 1995;13:2776\u201383.","journal-title":"J Clin Oncol"},{"key":"350_CR20","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/bjc.1992.373","volume":"66","author":"AC Haffner","year":"1992","unstructured":"Haffner AC, Garbe C, Burg G, B\u00fcttner P, Orfanos CE, Rassner G, et al. The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients. Br J Cancer. 1992;66:856\u201361.","journal-title":"Br J Cancer"},{"key":"350_CR21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/1097-0142(19830801)52:3<575::AID-CNCR2820520333>3.0.CO;2-6","volume":"52","author":"CP Karakousis","year":"1983","unstructured":"Karakousis CP, Temple DF, Moore R, Ambrus JL. Prognostic parameters in recurrent malignant melanoma. Cancer. 1983;52:575\u20139.","journal-title":"Cancer"},{"key":"350_CR22","first-page":"262","volume":"172","author":"DF Roses","year":"1991","unstructured":"Roses DF, Karp NS, Oratz R, Dubin N, Harris MN, Speyer J, et al. Survival with regional and distant metastases from cutaneous malignant melanoma. Surg Gynecol Obstet. 1991;172:262\u20138.","journal-title":"Surg Gynecol Obstet"},{"key":"350_CR23","first-page":"111","volume":"164","author":"CM Sutherland","year":"1987","unstructured":"Sutherland CM, Mather FJ, Krementz ET. Factors influencing the survival of patients with regional melanoma of the extremity treated by perfusion. Surg Gynecol Obstet. 1987;164:111\u20138.","journal-title":"Surg Gynecol Obstet"},{"key":"350_CR24","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1200\/JCO.2006.06.3198","volume":"24","author":"N Cascinelli","year":"2006","unstructured":"Cascinelli N, Bombardieri E, Bufalino R, Camerini T, Carbone A, Clemente C, et al. Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival. J Clin Oncol. 2006;24:4464\u201371.","journal-title":"J Clin Oncol"},{"key":"350_CR25","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/modpathol.3800117","volume":"17","author":"AJ Cochran","year":"2004","unstructured":"Cochran AJ, Wen DR, Huang RR, Wang HJ, Elashoff R, Morton DL. Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol. 2004;17:747\u201355.","journal-title":"Mod Pathol"},{"issue":"1","key":"350_CR26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1245\/s10434-008-0187-5","volume":"16","author":"C Ariyan","year":"2009","unstructured":"Ariyan C, Brady MS, Gonen M, Busam K, Coit D. Positive nonsentinel node status predicts mortality in patients with cutaneous melanoma. Ann Surg Oncol. 2009;16(1):186\u201390.","journal-title":"Ann Surg Oncol"},{"key":"350_CR27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/j.seminoncol.2007.09.007","volume":"34","author":"AN Crowson","year":"2007","unstructured":"Crowson AN, Magro C, Miller A, Mihm MC Jr. The molecular basis of melanomagenesis and the metastatic phenotype. Semin Oncol. 2007;34:476\u201390.","journal-title":"Semin Oncol"},{"key":"350_CR28","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1038\/sj.bjc.6603763","volume":"96","author":"ME Polak","year":"2007","unstructured":"Polak ME, Borthwick NJ, Gabriel FG, Johnson P, Higgins B, Hurren J, et al. Mechanisms of local immunosuppression in cutaneous melanoma. Br J Cancer. 2007;96:1879\u201387.","journal-title":"Br J Cancer"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-009-0350-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-009-0350-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-009-0350-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T11:32:26Z","timestamp":1572953546000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-009-0350-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,18]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["350"],"URL":"https:\/\/doi.org\/10.1245\/s10434-009-0350-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,18]]}}}